Otc Pet Medication Market

Global Market Study on OTC Pet Medication: Increasing Pet Humanization Trend Giving Impetus to Market Growth

OTC Pet Medication Market

Introduction

Pet ownership has been increasing across the world, primarily driven by changes in lifestyle, increase in disposable income, and more people wanting pets as companions. These factors, in turn, increase in subsequent or parallel industries such OTC pet medication. Increasing pet ownership and awareness related to pet diseases or pet health have fuelled the demand for OTC pet medication.

In the OTC pet medication market, companies are offering pet medicines at competitive prices through various sales channels such as drug & pharmacy stores, pet specialty stores, etc. OTC pet medications are also available through online platforms, which has become a lucrative sales channel for the OTC pet medication market.

Find Out More about the Report Coverage

Companies

  • Bayer Companion Animal
  • Boehringer Ingelheim Animal Health
  • Ceva Sante Animale
  • Merck Inc.
  • Zoetis Inc.
  • Elanco
  • Virbac SA
  • Vetoquinol SA
  • Frontline
  • Zymox
  • ChloraSeb
  • Sulfox
  • Adequan
  • Dechra Pharmaceuticals PLC
  • Nutramax Laboratories, Inc.
  • Others (On Request)

Rising Demand for Flea & Tick and Pain Relief & Arthritis Products

Flea allergy dermatitis and lyme disease are common types of diseases carried and transmitted by fleas & ticks. The second-most common health issue found among pets is arthritis. The OTC pet medication market is primarily driven by flea & tick and pain relief & arthritis products.

These products, combined, hold 70% of the total OTC pet medication market share. Increasing usage of flea & tick and pain relief & arthritis products is majorly driven by the potential risk of transmission to humans.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

COVID-19 Impact on OTC Pet Medication Market

Social distancing and lockdowns across in most countries have interrupted the production and supply of goods and raw materials in the OTC pet medication market space. Most retail operations have been shut down temporarily, which is lowering the sales of OTC pet medication products.

This has resulted in lower OTC pet medication sales volume in the first quarter of 2020. The market is expected to recover in 2021, with East & South Asia are projected to witness higher growth rates as compared to other markets.

otc pet medication market

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

OTC Pet Medication Market: Competition Analysis

The global OTC pet medication market is fairly consolidated in nature, where, a majority of players focus on product formulation & development, regular product launches, and mergers & acquisitions.

  • Collaborations and acquisition of niche players is a key strategy being followed by leading OTC pet medication manufacturers.
  • In 2018, Zoetis Inc. expanded its animal vaccines research and manufacturing in Suzhou, China. The company is focusing on the development and manufacturing of vaccines and supplements for companion animals, fish, cattle, and pigs.  It is also planning to expand its physical presence by establishing new manufacturing and distribution centers in east China.
  • Several OTC pet medication companies are significantly spending more on promotional activities, expanding their physical store presence, and entering into strategic partnerships with prominent partners such as Walmart and 1800petmed for increasing their share in the OTC pet medication landscape.

Explore Persistence Market Research’s expertise in promulgation of the business !

Regional Overview of Global OTC Pet Medication Market

The OTC pet medication market is estimated to be valued at US$ 8.3 Bn in 2020. According to PMR’s report, the market is estimated to register a CAGR of over 4% during the forecast period of 2020-2030.

North America remains the largest shareholder in the global OTC pet medication market, followed by Europe. The U.S. has emerged as a dominant country in OTC pet medication in terms of consumption. East Asia, South Asia, and Latin America will offer substantial growth opportunities for the OTC pet medication market.

Analysts’ Viewpoint

A brief overview of the changing landscape of the OTC pet medication market has led our analysts to conclude that, the market is gaining momentum. Key manufacturers in the OTC pet medication market, such as Boehringer Ingelheim Animal Health, Bayer Companion Animal, and Merck & Co., Inc., are prioritizing innovation and new product development to gain a competitive edge in the market. Most companies are currently focusing on new innovation through new formulation development and new product launches such as natural OTC medication for pets. Apart from developed countries, companies can focus on emerging markets such as China, India, Brazil, etc.

OTC Pet Medication Market: Segmentation

PMR’s research study on the global OTC pet medication market offers a detailed market taxonomy, wherein, key segments have been discussed in detail. The OTC pet medication market is segmented on the basis of application, pet, form, sales channel, and region. Every segment is analyzed in detail, and data pertaining to the growth of each segment has been included in the study.

Application

  • Fleas & Ticks
  • Pain Relief & Arthritis
  • Dewormers
  • Others

 

Pet

  • Dogs
  • Cats
  • Birds
  • Fish and Reptiles
  • Small Pets
  • Others

 

Form

  • Chewables & Tablets
  • Capsules & Ointment
  • Sprays
  • Others

 

Sales Channel

  • Pet Specialty Stores
  • Veterinary Clinics
  • Drug & Pharmacy Stores
  • Online Retail
  • Others

 

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

 

The OTC pet medication market research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are Boehringer Ingelheim Animal Health, Ceva Sante Animale, Bayer Companion Animal, Merck Inc., Zoetis Inc., Elanco, Virbac SA, Vetoquinol SA, Frontline, Elanco, and others.

OTC Pet Medication Market: Key Questions Answered in the Report

The research study on the OTC pet medication market offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the OTC pet medication market report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.

  • How is the rapidly changing business environment impacting the growth of the OTC pet medication market?
  • What are the key trends that are constantly shaping the growth of the OTC pet medication market?
  • Which are the prominent regions that offer plentiful opportunities for players in the OTC pet medication market?
  • What are the differential strategies adopted by key players to hold a significant share in the global OTC pet medication market?

Media Release

Our Clients

Our Clients